APPENDIX 3

Pfizer 10-k Disclosures, 2012

Pfizer, Inc., is a large biopharmaceutical manufacturer and a member of the Dow Jones Industrial Average (DOW). With a market capitalization about $200 billion, it is one of America’s largest corporations. Pfizer’s financial disclosures for fiscal year 2012 will be used (based on the 2012 10-K) to present the extensive disclosures required by public corporations for both compensation and retirement reporting. Note 13 in the 2012 10-k describes share-based payments: “Our compensation programs can include share-based payments, in the form of stock options, Restricted Stock Units (RSUs), Portfolio Performance Shares (PPSs), Performance Share Awards (PSAs) and Total Shareholder Return Units (TSRUs).” Table ...

Get Executive Compensation now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.